THE OLD CONFLICT BETWEEN DRUG INNOVATION AND CONTROL Newsletter Article 15 February 2013 Pages: 2 - 2
DRUGS FOR COLITIS — THERE ARE STILL MANY QUESTIONS TO ANSWER Newsletter Article 15 February 2013 Pages: 3 - 3
LONG-TERM SAFETY OF β-BLOCKERS IS STILL IN THE BALANCE Newsletter Article 15 February 2013 Pages: 3 - 3
CEPHAMANDOLE — NO MATCH FOR SOME OF ITS OLDER RELATIVES? Newsletter Article 15 February 2013 Pages: 4 - 4
DEATH FROM POISONING — AN IMPORTANT PUBLIC HEALTH PROBLEM Newsletter Article 15 February 2013 Pages: 5 - 5
PRE-OPERATIVE POVIDONE IODINE VAGINAL PESSARIES MAY BE HAZARDOUS Newsletter Article 15 February 2013 Pages: 6 - 6
DISAPPOINTING RESULTS WITH BRL 10833 IN IDIOPATHIC NEPHROTIC SYNDROME Newsletter Article 15 February 2013 Pages: 8 - 8
LORCAINIDE: A Promising New Antiarrhythmic from Janssen Newsletter Article 15 February 2013 Pages: 8 - 8
GLAZIOVINE: AN INTERESTING NEW PRO-APORPHINE ALKALOID Newsletter Article 15 February 2013 Pages: 8 - 8
BROMHEXINE IS A RELEVANT FIRST CHOICE FOR SJÖGREN’S SYNDROME Newsletter Article 15 February 2013 Pages: 9 - 9
DOES FOOD AFFECT GASTROINTESTINAL ABSORPTION OF HYDROCHLOROTHIAZIDE? Newsletter Article 15 February 2013 Pages: 13 - 13
GLIPIZIDE IS A POTENT AND RAPIDLY ACTING ANTIDIABETIC AGENT Newsletter Article 15 February 2013 Pages: 15 - 15
CLONIDINE SIDE EFFECTS ARE CLOSELY RELATED TO SERUM LEVELS Newsletter Article 15 February 2013 Pages: 15 - 15
CANCER CHEMOTHERAPY — AN ALTERNATIVE TO ‘TRIAL AND ERROR’? Newsletter Article 15 February 2013 Pages: 15 - 15
CEPHAMANDOLE: ANOTHER PARENTERAL ADDITION TO THE CEPHALOSPORIN RANGE Newsletter Article 15 February 2013 Pages: 16 - 17
KEEPING DOWN THE LIPID LEVELS — A look at the drugs available (contd) Newsletter Article 15 February 2013 Pages: 19 - 20